Drug susceptibility of Mycobacterium leprae: A retrospective analysis of mouse footpad inoculation results from 1983 to 1997

Leprosy Review

Volumn 73, Issue 3, 2002, Pages 239-244

  Sekar, B ^a   Elangeswaran, N ^a   Jayarama, E ^a   Rajendran, M ^a   Kumar, S S ^a   Vijayaraghavan, R ^a   Anandan, D ^a   Arunagiri, K ^a  

^a Central Leprosy Teaching and Research Institute India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; LEPROSTATIC AGENT; OFLOXACIN; RIFAMPICIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; FOOT PAD; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MALE; MOUSE; MYCOBACTERIUM LEPRAE; NONHUMAN; RELAPSE; RETROSPECTIVE STUDY;

EID: 0036746581     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Noordeen SK. Eliminating leprosy as a public health problem - is the optimism justified? World Health Forum, 1996; 17: 109-118.
2. WHO Weekly Epidemiological Record No. 28,14, July 2000.
3. Pablos-Mendez A, Raviglione MC, Laszlo A. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med, 1998; 338: 1641-1649.
4. Grosset JH, JI B, Ito T. The first joint THELEP - Sasakawa Memorial Health Foundation workshop on experimental chemotherapy of leprosy. Int J Lepr, 1987; 55: 807-813.
5. McRae DH, Shepard CC. Relationship between the staining quality of Mycobacterium leprae and infectivity to mice. Infect Immun, 1971; 3: 116-120.
6. Levy L. The normal mouse in experimental chemotherapy. Int J Lepr, 1987; 55: 843-846.
7. Desikan KV, Venkataramaniah HN. A modified method of harvesting M. leprae from footpads of mice. Lepr Ind, 1976; 48: 157-162.
8. Balakrishnan S, Seshadri PS, Neelan PN et al. Studies on sulphone resistant strains of M. leprae in field and institutionalised cases of leprosy. Lepr Ind, 1983; 55: 71-75.
9. Bhatia VN, Balakrishnan S, Sehadri PS et al. Dapsone resistance in patients attending Central Leprosy Teaching and Research Institute, Chengalpattu (South India). Ind J Lepr, 1984; 56: 587-594.
10. WHO 1987. Laboratory techniques for leprosy. World Health Organization, Geneva.
11. Kar HK, Bhatia VN, Harikrshnan S. Combined clofazimine and dapsone-resistant leprosy. A case report. Int J Lepr, 1986; 54: 389-391.
12. Aschhoff M, Irudayaraj PP, Lilly L, Srinivasan H. Secondary and primary dapsone resistant leprosy: an analysis of 199 patients from St Thomas Hospital and Leprosy Project, Chengalpattu, South India. Ind J Lepr, 1988; 60: 34-46.
13. Almeida JG, Chacko CJG, Christian M. The significance of dapsone (DDS)-resistant mycobacterium leprae in untreated patients. Int J Lepr, 1983; 51: 374-377.
14. Sreevatasa, Girdhar BK, Ramu G, Desikan KV. Dapsone resistance in North India. Ind J Lepr, 1985; 57: 514-518.
15. Grosset JH, Guelpa-Lauras CC, Bobin P. Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin. Int J Lepr, 1989; 57: 607-614.
16. Cambau E, Parani E, Guillemin I et al. Multi drug resistance to dapsone, rifampin and ofloxacin in Mycobacterium leprae. Lancet, 1997; 349: 103-104.
17. Wandorff-Van Diepen, T. Clofazimine resistant leprosy; a case report. Int J Lepr, 1982; 50: 139-142.
18. Levy, L. Clofazimine resistant M. leprae (Letter). Int J Lepr, 1986; 54: 137-140.
19. Gupta UD, Katoch K, Singh HB et al. Assessment of viability by normal MFP and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxaxcin. Ind J Lepr, 2000; 72: 437-442.
20. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP). Scientific working group of the UNDP/World Bank/WHO special programme for research and training in tropical diseases. The THELEP controlled clinical drug trials. Int J Lepr, 1987; 55: 864-871.